October is Breast Cancer Awareness Month in the U.S., meaning now is the time to learn more about the disease, the genetic component to a common breast cancer medication and…
Read More
A recent Mayo Clinic study has found that clinical recommendations discouraging the use of CYP2D6 genetic testing to advise tamoxifen treatment in women with breast cancer should be reconsidered because…
Read More
